Get Fda 3926 2015
How it works
-
Open form follow the instructions
-
Easily sign the form with your finger
-
Send filled & signed form or save
How to fill out the FDA 3926 online
This guide provides step-by-step instructions on how to complete the FDA Form 3926 for individual patient expanded access requests. Designed for licensed physicians, this streamlined form facilitates the submission of investigational new drug applications for patients with serious conditions.
Follow the steps to complete the FDA 3926 form online.
- Press the ‘Get Form’ button to acquire the form, which will open in the designated editor.
- In Box 1, enter the patient’s initials and the date of submission. Use initials to maintain confidentiality.
- For Box 2, provide the clinical information that includes the indication, a brief clinical history of the patient, and the rationale for the treatment request.
- In Box 3, detail the treatment information. Include the investigational drug’s name, planned dose, route, schedule, and monitoring procedures.
- If applicable, attach the letter of authorization (LOA) in Box 4, which allows the FDA to reference the manufacturer’s information related to the investigational drug.
- In Box 5, include the physician’s qualification statement. You may opt to attach relevant pages of the physician’s curriculum vitae.
- Fill Box 6 with the physician's name, contact information, and any previously assigned IND number.
- Box 7 consists of a request for authorization to use Form FDA 3926 for IND submission. Confirm that completed form will comply with FDA regulations.
- Finally, in Box 8, provide the certification statement and signature, attesting that treatment will not begin until 30 days after submission unless earlier notified by the FDA.
- Once all sections are completed, save your changes, and download or print the form as needed for submission.
Start submitting your documents online for efficient processing!
Get form
The FDA approval process for new drugs involves several key stages, beginning with preclinical research and followed by clinical trials. Once trials are completed, the manufacturer submits a New Drug Application (NDA) for FDA evaluation. The FDA reviews all data, discusses it with advisory committees, and may request more information. Your understanding of the FDA 3926 will significantly benefit you throughout this complex process.
Get This Form Now!
Industry-leading security and compliance
-
In businnes since 199725+ years providing professional legal documents.
-
Accredited businessGuarantees that a business meets BBB accreditation standards in the US and Canada.
-
Secured by BraintreeValidated Level 1 PCI DSS compliant payment gateway that accepts most major credit and debit card brands from across the globe.